Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0001415889-25-019002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-02 | 2025-06-30 | STOK | LEVIN ARTHUR A | Dir | M - OptEx | $0.00 | +1,210 | 2,420 | +100% | $0 |
| D | 2025-07-02 | 2025-06-30 | STOK | LEVIN ARTHUR A | Dir | M - OptEx | $0.00 | -1,210 | 2,422 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-30 | M | A | 1,210 | $0.00 | 2,420 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-06-30 | M | D | 1,210 | $0.00 | 2,422 | D | — · — to 2025-12-31 | 1,210 Common Stock | (F1) Each Restricted Stock Unit represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F2) The award vested or vests as to 1/4 of the total award quarterly on the last day of March, June, September, and December, subject to the reporting person's continued service to the issuer through each vesting date. |